2024 Exhibitors Search
Xcell Therapeutics Inc

Exhibit Item |
[KOREA LIFE SCIENCE WEEK] Bio·Medical·Pharma
|
---|---|
Country | Korea, South |
Tel (Rep.) | 070-8896-7932 |
Website | http://www.xcell.co.kr/kor/ |
Company Introduction
Since our inception in 2015, Xcell Therapeutics’ focus has been to create a better future for humanity through the application and use of ethical science. With 10 years of research, we have made a breakthrough and developed CellCor™, a serum-free chemically defined media composed of over 200 known compounds. CellCor™ does not contain any animal or plant-derived components, making it a pure CD media.
Today, we are working with a team of talented researchers in the R&D section. We are currently working on developing proliferation media for various animal cell types. Our research team guarantees to use ethical technologies and tools for our research.
It is our goal to become the CDMO leader in regenerative medicine within the next 10 years and build a world where innovation in life sciences is as ethical as it is revolutionary.
Today, we are working with a team of talented researchers in the R&D section. We are currently working on developing proliferation media for various animal cell types. Our research team guarantees to use ethical technologies and tools for our research.
It is our goal to become the CDMO leader in regenerative medicine within the next 10 years and build a world where innovation in life sciences is as ethical as it is revolutionary.
Promotional Video
Exhibit Item
Exhibit Description
CellCor™ MSC CD AOF can be used to cultivate stably until the second half of the subculture and maintains stable stemness. In addition, it maintains low aging and high genetic stability of cells and is applicable for mesenchymal stem cells derived from various tissues and is applicable to stem cell-derived exosomes production and research.
Co-Exhibitor or
Partner’s Information
Company Name | Country | Website |
---|---|---|
woongbee | Korea, South | www.woongbee.com/ |